Chat with Client Services
Site Search
A survey of laboratory professionals led by ARUP experts clarified factors that contribute to the success of laboratory stewardship programs.
ARUP medical directors and scientists will share their research and expertise in areas like lab stewardship, biochemical genetics, and neonatal drug testing at AACC’s 2022 annual meeting in Chicago.
ARUP Healthcare Advisory Services will lead a roundtable exercise on building strong laboratory stewardship programs at the American Society for Clinical Pathology (ASCP) KnowledgeLab in Boston.
ARUP study finds pharmacogenetic testing to evaluate drug-gene interactions improves patient outcomes and patients' confidence in overall care.
ARUP Laboratories has renamed its expert team of healthcare consultants as ARUP Healthcare Advisory Services. The new name better reflects the broad service offerings the team can provide.
Join us for a look at ARUP’s accomplishments in scientific innovation and meet our committed scientists, laboratory professionals, and healthcare advisory consultants who make ARUP an industry leader.
Andrew Fletcher, MD, medical director of Consultative Services at ARUP Laboratories, and ARUP’s Consultative Services team, led by Sandy Richman, are honored with 2021 Choosing Wisely Champion Awards.
ARUP Laboratories’ inaugural Lab Leadership Symposium, “Creating Connections: Advancing Your Lab’s Value in the Healthcare System” will be held Thursday, October 21, 2021.
ARUP Laboratories Senior Pharmacy Consultant Ryan Nelson, PharmD, is on a quest to share how underused pharmacogenomic testing can help identify and enable guideline-supported therapies.
Andrew Fletcher, MD, ARUP Laboratories Medical Director of Consultative Services, has earned Health Care Quality and Management certification from the ABQAURP.
Andrew Fletcher, MD, MBA, CPE, CHCQM, FCAP, medical director of Consultative Services at ARUP, has coauthored a study that shows clinicians frequently do not adhere to clinical guidelines.
Before the pandemic, telemedicine accounted for less than 1% of all physician visits, but that number spiked to over 50% after the appearance of COVID-19 cases in the United States.
